Stated preferences for relapsed or refractory mantle cell lymphoma treatments in Sweden and Germany

被引：7
作者：
Eriksson, Jennifer [1 ]
Landfeldt, Erik [1 ,2 ]
Ireland, Steve [3 ]
Jackson, Claire [4 ]
Wyatt, Emma [4 ]
Gaudig, Maren [5 ]
机构：
[1] ICON Plc, Stockholm, Sweden
[2] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden
[3] Janssen EMEA Business Intelligence, High Wycombe, Bucks, England
[4] Adelphi Res UK, Bollington, England
[5] Janssen Hlth Econ & Market Access EMEA, Neuss, Germany
来源：
FUTURE ONCOLOGY | 2020年 / 16卷 / 13期
关键词：
discrete choice experiment; interview; overall survival; progression-free survival; treatment administration; treatment preference; DISCRETE-CHOICE EXPERIMENTS; METASTATIC BREAST-CANCER; PATIENT PREFERENCES; CONJOINT-ANALYSIS; TREATMENT DECISIONS; THERAPY; GUIDELINES; PHYSICIANS; OPTIONS; WOMEN;
D O I：
10.2217/fon-2020-0018
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Background: We aimed to elicit treatment preferences in relapsed/refractory mantle cell lymphoma (r/r MCL). Materials & methods: A discrete-choice experiment comprising six attributes ('overall survival', 'progression-free survival', 'fatigue', 'nausea', 'risk of serious infections' and 'treatment administration') was administered to r/r MCL patients, physicians and the general population (GP) in Sweden and Germany. Results: 18 patients, 68 physicians and 191 GP members participated. 'Overall survival' was the most important attribute, followed by 'risk of serious infection' and 'progression-free survival' among physicians and the GP. In contrast, 'treatment administration' was the second most important attribute to patients, followed by 'risk of serious infection.' Conclusion: Preferences for characteristics differentiating treatments of r/r MCL varies between patients, physicians and members of the GP.
引用
收藏
页码：859 / 868
页数：10
相关论文
共 25 条
[1]   Patient preferences for chemotherapies used in breast cancer [J].
Beusterien, Kathleen ;
Grinspan, Jessica ;
Tencer, Thomas ;
Brufsky, Adam ;
Visovsky, Constance .
INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2012, 4 :279-287
[2]   Patients' preferences for treatment outcomes for advanced non-small cell lung cancer: A conjoint analysis [J].
Bridges, John F. P. ;
Mohamed, Ateesha F. ;
Finnern, Henrik W. ;
Woehl, Anette ;
Hauber, A. Brett .
LUNG CANCER, 2012, 77 (01) :224-231
[3]   Conjoint Analysis Applications in Health-a Checklist: A Report of the ISPOR Good Research Practices for Conjoint Analysis Task Force [J].
Bridges, John F. P. ;
Hauber, A. Brett ;
Marshall, Deborah ;
Lloyd, Andrew ;
Prosser, Lisa A. ;
Regier, Dean A. ;
Johnson, F. Reed ;
Mauskopf, Josephine .
VALUE IN HEALTH, 2011, 14 (04) :403-413
[4]   Patient preferences versus physician perceptions of treatment decisions in cancer care [J].
Bruera, E ;
Sweeney, C ;
Calder, K ;
Palmer, L ;
Benisch-Tolley, S .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (11) :2883-2885
[5]  
Dreyling M, 2017, ANN ONCOL, V28, P62, DOI [10.1093/annonc/mdx289, 10.1093/annonc/mdx223]
[6]   ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma [J].
Dreyling, M. ;
Thieblemont, C. ;
Gallamini, A. ;
Arcaini, L. ;
Campo, E. ;
Hermine, O. ;
Kluin-Nelemans, J. C. ;
Ladetto, M. ;
Le Gouill, S. ;
Iannitto, E. ;
Pileri, S. ;
Rodriguez, J. ;
Schmitz, N. ;
Wotherspoon, A. ;
Zinzani, P. ;
Zucca, E. .
ANNALS OF ONCOLOGY, 2013, 24 (04) :857-877
[7]  
Hauber AB, 2016, VALUE HEALTH, V19, P300, DOI 10.1016/j.jval.2016.04.004
[8]   Patient preferences for palliative treatment of locally advanced or metastatic gastric cancer and adenocarcinoma of the gastroesophageal junction: a choice-based conjoint analysis study from Germany [J].
Hofheinz, R. ;
Clouth, J. ;
Borchardt-Wagner, J. ;
Wagner, U. ;
Weidling, E. ;
Jen, M. H. ;
Brueck, P. .
BMC CANCER, 2016, 16
[9]   Use of the metastatic breast cancer progression (MBC-P) questionnaire to assess the value of progression-free survival for women with metastatic breast cancer [J].
Hurvitz, Sara A. ;
Lalla, Deepa ;
Crosby, Ross D. ;
Mathias, Susan D. .
BREAST CANCER RESEARCH AND TREATMENT, 2013, 142 (03) :603-609
[10]   Patient, physician, and general population preferences for treatment characteristics in relapsed or refractory chronic lymphocytic leukemia: A conjoint analysis [J].
Landfeldt, Erik ;
Eriksson, Jennifer ;
Ireland, Steve ;
Musingarimi, Patience ;
Jackson, Claire ;
Tweats, Emma ;
Gaudig, Maren .
LEUKEMIA RESEARCH, 2016, 40 :17-23
123